StockWatch: Pfizer Pill Enters Phase 1
Pfizer has initiated the Phase I trial of an anti-Covid-19 pill that could be given to patients showing early signs of illness.
The pill could be used in the early treatment of coronavirus disease and to address future threats.
Johnson&Johnson has seen successful rollouts of their vaccine so far. Since the vaccination only requires a single dose, this could be key if #vaccines are in short supply.
– PFE 02:50
– JNJ 04:05